Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
249.36
-0.89 (-0.36%)
Aug 27, 2026, 4:00 PM EDT - Market closed
Ascendis Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $345 | Buy | Initiates | $345 | +38.35% | Aug 27, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $275 | Buy | Reiterates | $275 | +10.28% | Aug 24, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $300 | Buy | Maintains | $300 | +20.31% | Aug 20, 2026 |
| BMO Capital | BMO Capital | Buy Initiates $319 | Buy | Initiates | $319 | +27.93% | Aug 18, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $306 | Buy | Reiterates | $306 | +22.71% | Aug 14, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $300 | Buy | Reiterates | $300 | +20.31% | Aug 14, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $280 → $290 | Buy | Maintains | $280 → $290 | +16.30% | Aug 14, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $326 | Buy | Maintains | $326 | +30.73% | Aug 14, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.